Table 1.
Citation/ref. | Year | Study country | Study location | Study design | Disease tested | Study population | Biomarker(s) | Ranges (CRP/PCT) | Comparison | Outcomes tested |
---|---|---|---|---|---|---|---|---|---|---|
Sirijaichingkul et al.12 | 2005 | Thailand | Inpatient | Prospective cohort | CNS infections | 32 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for bacterial meningitis |
Abdelkader et al.13 | 2014 | Egypt | Emergency department | Prospective cohort | CNS infections | 40 | PCT | Not specified | Non-comparative | Diagnostic value of PCT at admission and 3 days after treatment for bacterial meningitis |
Alavi et al.14 | 2012 | Iran | Inpatient | Prospective cohort | CNS infections | 36 | PCT | 0.5 ng/mL | Non-comparative | Prognostic value of early (24 h) decrease in PCT |
Koegelenberg et al.15 | 2004. | S Africa | Inpatient | Prospective cohort | Endocarditis | 92 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for infective endocarditis |
Inan et al.16 | 2010 | Turkey | Inpatient (cardiac surgery) | Retrospective | Endocarditis (Brucella) | 31 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for Brucella endocarditis |
Mohanan et al.17 | 2018 | India | Inpatient | Prospective cohort | Endocarditis | 178 | CRP | <3 mg/L | Non-comparative | Prognostic value of CRP for infective endocarditis |
Do et al.18 | 2016 | Vietnam | Outpatient | Randomized controlled trial | Acute respiratory tract infection | 2036 | CRP | 20 mg/L | No biomarker (routine care) | Diagnostic value of CRP in non-severe acute respiratory tract infection |
Blake et al.19 | 2017 | Togo | Inpatient | Prospective cohort | Acute respiratory tract infection | 1684 | CRP | Not specified | Lyt A rtPCR, blood culture, CXR | Diagnostic value of CRP in community-acquired pneumonia |
Borsi et al.20 | 2019 | Iran | Emergency department, and outpatient | Retrospective | Acute respiratory tract infection | 50 | PCT | Not specified | Non-comparative | Diagnostic value of PCT in acute exacerbation of COPD |
Nyamande et al.21 | 2006 | S Africa | Inpatient | Prospective cohort | Acute respiratory tract infection | 266 | PCT | Not specified | Non-comparative | Diagnostic value of PCT for community-acquired pneumonia/and TB in HIV patients |
Mendelson et al.22 | 2018 | S Africa | Inpatient | Prospective cohort | Acute respiratory tract infection | 210 | CRP, PCT | CRP 10 mg/L, PCT 0.02 μg/L | Composite reference standards | Diagnostic value of PCT and CRP for respiratory tract infections in HIV patients |
Sharma et al.23 | 2016 | India | ICU | Prospective cohort | ARDS | 64 | CRP, PCT, IL-1β, IL-6, TNF-α | Not specified | Non-comparative | Prognostic value of PCT and CRP for ARDS patients |
Wang et al.24 | 2019 | Uganda | Inpatient | Cross-sectional | Acute respiratory tract infection | 173 | CRP | Not specified | Non-comparative | Prognostic value of CRP for respiratory tract infections in HIV patients |
Saldias-Penafiel et al.25 | 2019 | Chile | Inpatient | Prospective cohort | Acute respiratory tract infection | 823 | CRP | 0–0.5 mg/dL | Non-comparative | Diagnostic and prognostic value of CRP for community-acquired pneumonia |
El Maghraby et al.26 | 2020 | Egypt | Inpatient | Cross-sectional | Acute respiratory tract infection | 240 | PCT | Not specified | Non-comparative | Diagnostic and prognostic value of PCT for community-acquired pneumonia |
Tokman et al.27 | 2014 | Uganda | Inpatient | Prospective cohort | Acute respiratory tract infection | 635 | PCT | 0.02−0.5 ng/mL | Non-comparative | Prognostic value of PCT for lower respiratory tract infections in HIV patients |
Seligman et al.28 | 2011 | Brazil | ICU | Observatonal cohort | Acute respiratory tract infection | 71 | PCT, CRP, MR-proANP, copeptin | CRP not specified, PCT 0.1 ng/mL, copeptin 2.25 pmol/L, MR-proANP 1 pmol/L | Non-comparative | Prognostic value of PCT and CRP for ventilator-associated pneumonia |
Kiaei et al.29 | 2015 | Iran | ICU | Retrospective | Acute respiratory tract infection | 50 | PCT, CRP | Not specified | Non-comparative | Efficacy of PCT and CRP in determining antibiotic therapy duration in patients with ventilator-associated pneumonia |
Wongsurakiat and Tulatamakit30 | 2018 | Thailand | ICU | Prospective non-randomized controlled study | Acute respiratory tract infection | 71 | PCT | 0.02–100 ng/mL | No biomarker (clinical score) | Efficacy of PCT in determining antibiotic therapy duration in patients with ventilator-associated pneumonia |
Mohd et al.31 | 2021 | Malaysia | ICU | Prospective interventional single-blinded | Acute respiratory tract infection | 85 | PCT | < 0.25 ng/mL | No biomarker (routine care) | Efficacy of PCT in determining antibiotic therapy duration in patients with ventilator-associated pneumonia |
El-Amin et al.32 | 2017 | Egypt | Inpatient | Cross-sectional descriptive study | Intra-abdominal infections | 100 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for infection among patients with liver cirrhosis |
Godinez-Vidal et al.33 | 2019 | México | Inpatient | Retrospective, descriptive, cross-sectional | Intra-abdominal infections | 99 | PCT | >10.1 ng/mL | Non-comparative | Prognostic value of PCT in abdominal sepsis |
Orati et al.34 | 2013 | Brazil | ICU | Retrospective cohort | Intra-abdominal infections | 345 | CRP | Not specified | Non-comparative | Diagnostic value of CRP in abdominal sepsis |
Trivedi et al.35 | 2016 | India | Inpatient | Retrospective | Urinary tract infections | 122 | CRP | Not specified | Non-comparative | Diagnostic value of CRP in urinary sepsis |
Ndamason et al.36 | 2019 | Cameroon | Inpatient | Cross-sectional | Urinary tract infections | 128 | CRP | Not specified | Non-comparative | Diagnostic value of CRP in urinary sepsis |
Arjunlal et al.37 | 2020 | India | Inpatient | Prospective | Urinary tract infections | 64 | CRP | Not specified | Non-comparative | Prognostic value of CRP in urinary sepsis |
Agrawal et al.38 | 2015 | India | Inpatient | Retrospective | Bone and joint infection | 81 | CRP | Not specified | Non-comparative | Diagnostic value of CRP in osteoarticular infections |
George et al.39 | 2019 | India | Inpatient | Retrospective | Bone and joint infection | 70 | CRP | Not specified | Non-comparative | Diagnostic value of CRP in septic arthritis |
Waheed et al.40 | 2019 | Egypt | Inpatient | Prospective | Bone and joint infection | 44 | CRP | Not specified | Non-comparative | Prognostic value of CRP in patients with spondylodiscitis |
Sharma et al.41 | 2012 | India | Inpatient | Prospective | Bone and joint infection | 20 | CRP | 11 mg/dL | Non-comparative | Prognostic value of CRP in patients with severe odontogenic infections |
Umapathy et al.42 | 2018 | India | Inpatient | Cross-sectional case-control | Skin and soft tissue infections | 185 | PCT | 30 pg/mL | Biomarkers (CRP, ESR, WBC) | Prognostic value of PCT in diabetic patients with foot ulcers |
Bammigatti et al.43 | 2019 | India | Inpatient | Prospective observational | Skin and soft tissue infections | 327 | PCT | 0.03 ng/mL | Non-comparative | Prognostic value of PCT in patients with snake bites |
Yousef et al.44 | 2010 | Egypt | ICU | Prospective observational | Sepsis and bloodstream infections | 106 | CRP, leptin, IL-6 and TNF-α | Not specified | Non-comparative | Prognostic value of CRP in patients with sepsis |
Mamani et al.45 | 2012 | Iran | Inpatient | Case-control | Sepsis and bloodstream infections | 90 | CRP, fibronectin | Not applicable | Non-comparative | Prognostic value of CRP in patients with sepsis |
Ali et al.46 | 2017 | Pakistan | ICU | Case series | Sepsis and bloodstream infections | 32 | CRP, lactate | Not specified | Non-comparative | Prognostic value of CRP in patients with sepsis |
Talebi-Taher et al.47 | 2014 | Iran | Emergency department | Prospective | Sepsis and bloodstream infections | 150 | CRP | PCT: 0.5 ng/mL; IL-6: 10 pg/µL, ESR: 17 mm/h for men and 25 mm/h for women; CRP ≥12 mg/L | ESR, PCT, IL-6 | Diagnostic value of CRP in elderly patients with sepsis |
Premaratna et al.48 | 2015 | Sri Lanka | Inpatient | Prospective | Sepsis and bloodstream infections | 40 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for sepsis in patients with dengue fever |
Gupta et al.49 | 2019 | India | Inpatient | Prospective | Sepsis and bloodstream infections | 305 | PCT | >0.5 ng/mL | Non-comparative | Diagnostic value of PCT in patients with sepsis |
Sinha et al.50 | 2011 | India | ICU | Prospective | Sepsis and bloodstream infections | 40 | PCT | >0.5 ng/mL | Non-comparative | Diagnostic value of PCT in patients with sepsis |
Ghorbani51 | 2009 | Iran | Emergency department | Cross-sectional | Sepsis and bloodstream infections | 100 | PCT | 0.05 ng/mL | Non-comparative | Diagnostic value of PCT in patients with sepsis |
Jain et al.52 | 2014 | India | ICU | Prospective | Sepsis and bloodstream infections | 54 | PCT | Not specifed | CRP | Prognostic value of PCT in patients with sepsis |
Rebello et al.53 | 2017 | India | Inpatient, ICU | Prospective observational | Sepsis and bloodstream infections | 112 | PCT | Not applicable | Non-comparative | Prognostic value of PCT in patients with sepsis |
Mehta et al.54 | 2016 | India | ICU | Retrospective observational study | Sepsis and bloodstream infections | 100 | PCT, BNP | Not specified | Non-comparative | Prognostic value of PCT and NTproBNP in ICU-admitted patients |
Dolatabadi et al.55 | 2015 | Iran | Emergency department | Cross sectional | Sepsis and bloodstream infections | 170 | PCT | 0.5 ng/mL | PCT before, 6 h after and 24 h after ATBs | Prognostic value of PCT in patients with sepsis |
Najafi et al.56 | 2015 | Iran | ICU | Prospective, single-blind randomized | Sepsis and bloodstream infections | 60 | PCT | Not specified | No biomarker | Prognostic value of PCT in patients with sepsis |
Lubell et al.57 | 2015 | Thailand, Cambodia, Laos | Inpatient/outpatient | Retrospective | Undifferentiated fever | 1372 | CRP, PCT | Not specified | Non-comparative | Diagnostic value of CRP, PCT in patients with undifferentiated fever |
Wangrangsimakul et al.58 | 2018 | Thailand | Inpatient | Prospective | Undifferentiated fever | 200 | CRP, PCT | Not specified | Non-comparative | Diagnostic value of CRP, PCT in patients with undifferentiated fever |
Phatlhane et al.59 | 2016 | S Africa | Outpatient | Cross-sectional | HIV | 110 | PCT, IL-6, LBP, CRP, IgG, albumin | Not specified | Non-comparative | Prognostic value of CRP, PCT in HIV-infected patients with diarrhoea |
Ramana et al.60 | 2013 | India | Outpatient | Prospective | HIV | 250 | CRP | Not specified | ESR, TLC, Hb, AEC | Prognostic value of CRP in HIV-infected patients with diarrhoea |
Zulu et al.61 | 2008 | Zambia | Not specified | Retrospective | HIV | 80 | CRP, TNFR p55, MIF, IL-6, IL-12, IFN-γ | 0.2 mg/L | Non-comparative | Prognostic value of CRP and cytokines in HIV-infected patients with diarrhoea |
Koethe et al.62 | 2011 | Zambia | Outpatient | Prospective observational cohort | HIV | 142 | CRP, albumin, ferritin | Not specified | Non-comparative | Prognostic value of CRP and other biomarkers in patients with malnutrition and advanced HIV |
Bedell et al.63 | 2018 | Malawi | Outpatient | Retrospective | HIV | 469 | CRP | 3.0 - 480 mg/L | Non-comparative | Diagnostic value of CRP for tuberculosis and bloodstream infections in HIV-infected patients |
Ledwaba et al.64 | 2012 | S Africa | Outpatient | Case-control | HIV | 187 | CRP, IL-6, D-dimer | CRP 1 mg/mL, IL-6 0.428-8.870 pg/L, D-Dimer 0.5 mg/L | Non-comparative | Prognostic value of CRP and other biomarkers in patients with advanced HIV |
Woodd et al.65 | 2016 | Zambia, Tanzania | Outpatient | Prospective | HIV | 1815 | CRP | Not specified | Non-comparative | Prognostic value of CRP in patients with advanced HIV |
Haddow et al.66 | 2012 | S Africa | Outpatient | Prospective | HIV | 498 | CRP | Not specified | Non-comparative | Prognostic value of CRP in patients with advanced HIV |
Sereti et al.67 | 2020 | Kenya, Thailand, USA | Outpatient | Prospective observational | HIV | 506 | CRP | Not specified | Non-comparative | Prognostic value of CRP in patients with advanced HIV |
Kroeze et al.68 | 2019 | Kenya, Nigeria, South Africa, Uganda, Zambia | Not specified | Retrospective | HIV | 398 | sCD14, sCD163, CRP, CXCL10, IL-6, CCL2, CXCL | Not specified | Non-comparative | Prognostic value of CRP in patients with advanced HIV |
Kiefer et al.69 | 2018 | Rwanda | Outpatient | Prospective | HIV | 695 | CRP, D-dimer, transthyretin | Not specified | Non-comparative | Prognostic value of CRP in patients with advanced HIV |
Chegou et al.70 | 2016 | S Africa, Uganda, Gambia, Malawi, Namibia | Outpatient | Prospective | 716 | TB | CRP, PCT | Not specified | IL-1ra, TGF-α, IFN-γ, IP-10, TNF-α, IFN-α2, VEGF, MMP-2, MMP-9, ApoA-1, Apo-CIII, transthyretin, CFH, SAA, SAP, fibrinogen, ferritin, TPA, haptoglobulin, α-2-macroglobulin | Diagnostic value of CRP, PCT and other biomarkers in patients with pulmonary TB |
Jacobs et al.71 | 2016 | S Africa | Outpatient | Prospective | TB | 55 | CRP, PCT | Not specified | NCAM, SAP, IL-1β, sCD40L, IL-13 and Apo A-1 | Diagnostic value of CRP, PCT and other biomarkers in patients with pulmonary TB |
Berrocal-Almanza et al.72 | 2016 | India | Outpatient | Prospective cohort | TB | 119 | CRP | Not specified | S100A12, sRAGE, esRAGE, HMGB-1, TNF-α, IFN-γ |
Prognostic value of CRP in TB |
Worodria et al.73 | 2011 | Uganda | Outpatient | Prospective | TB | 247 | CRP | <5 mg/L | Non-comparative | Diagnostic value of CRP, in HIV patients with pulmonary TB |
Yoon et al.74 | 2017 | Uganda | Outpatient | Prospective | TB | 1237 | CRP | >10 mg/L | Non-comparative | Diagnostic value of CRP for TB in people living with HIV/AIDS |
Rajopadhye et al.75 | 2017 | India | Not specified | Prospective | TB | 50 | CRP, NO, TBARS, SOD | Not specified | Non-comparative | Diagnostic value of CRP for TB in people living with HIV/AIDS |
Yoon et al.76 | 2019 | Uganda | Outpatient | Prospective | TB | 1245 | CRP | 8 mg/L | No biomarker (symptom-based screening) | Diagnostic value of CRP for TB in |
Ciccacci et al.77 | 2019 | Mozambique | Outpatient | Retrospective | TB | 155 | CRP | 10 mg/L | Neopterin, IP-10 | Diagnostic value of CRP for TB in people living with HIV/AIDS |
Olsson et al.78 | 2019 | Ethiopia | Outpatient | Prospective | TB | 260 | CRP, PCT | Not specified | CCL5, IP-10, IL-6, IL-12, IL-18, IL-27, IFN-γ, suPAR | Diagnostic value of CRP, PCT for TB in people living with HIV/AIDS |
Wilson et al.79 | 2011 | S Africa | Outpatient | Prospective | TB | 364 | CRP | Method 1: 0–8 mg/L Method 2: 0–5 mg/L |
Non-comparative | Diagnostic value of CRP for TB in people living with HIV/AIDS |
Lawn et al.80 | 2013 | S Africa | Outpatient | Prospective | TB | 496 | CRP | 50 mg/L | Non-comparative | Diagnostic and prognostic value of CRP for TB in people living with HIV/AIDS |
Farr et al.81 | 2018 | Uganda | Not specified | Retrospective | TB | 865 | CRP, cytokines | Not specified | Non-comparative | Diagnostic value of CRP and cytokines for TB in people living with HIV/AIDS |
de Oliveira et al.82 | 2019 | Brazil | Not specified | Retrospective | TB | 50 | CRP | <1 mg/dL | No biomarker (3D reconstructed lung imaging) | Prognostic value of CRP in TB |
Wilson et al.83 | 2018 | S Africa | Outpatient | Prospective cohort | TB | 421 | CRP | Not specified | Non-comparative | Prognostic value of CRP in TB |
Rasmussen et al.84 | 2011 | Guinea-Bissau | Outpatient | Prospective | TB | 218 | PCT CRP |
PCT 0.02–50 ng/mL CRP not specified |
CRP | Prognostic value of PCT in TB |
Janssen et al.85 | 2017 | S Africa | Inpatient | Prospective cohort | TB | 60 | PCT | Not specified | Non-comparative | Prognostic value of PCT for TB among HIVpatients |
Soedarsono et al.86 | 2019 | Indonesia | Outpatient | Prospective cohort | TB | 30 | CRP | 0.3−0.5 mg/dL | Non-comparative | Prognostic value of CRP in TB |
Epelboin L et al.87 | 2013 | French Guiana | Emergency department | Retrospective | Undifferentiated febrile illness | 416 | CRP | >5 mg/L | No biomarker (clinical score) | Diagnostic value of CRP for malaria and dengue fever |
Sanchez-Arcila et al.88 | 2014 | Brazil | Outpatient | Prospective | Malaria | 264 | CRP | 0.01–320 μg/mL | Non-comparative | Diagnostic value of CRP for malaria and intestinal parasites coinfection |
Peto et al.89 | 2016 | Cambodia | Outpatient | Prospective | Malaria | 328 | CRP | Not applicable | Non-comparative | Diagnostic value of CRP for malaria |
Gibson and Huddle90 | 1998 | Malawi | Outpatient | Prospective | Malaria | 152 | CRP | Not specified | Non-comparative | Diagnostic value of CRP for malaria in pregnancy |
Mockenhaupt et al.91 | 2000 | Ghana | Outpatient | Cross-sectional | Malaria | 530 | CRP | >0.6 mg/dL | Non-comparative | Diagnostic value of CRP for malaria in pregnancy |
Hinderaker et al.92 | 2002 | Tanzania | Outpatient | Prospective | Malaria | 2547 | CRP, ferritin, iron, TIBC, cobalamin, folate, vitamin A, LDH, TFsat | 10 mg/L | Non-comparative | Diagnostic value of CRP for malaria in pregnancy |
Adegnika et al.93 | 2006 | Gabon | Inpatient | Prospective | Malaria | 145 | CRP | 0.5 −6 mg/L | Non-comparative | Prognostic value of CRP for malaria in pregnancy |
Conroy et al.94 | 2011 | Malawi | Inpatient | Case-control | Malaria | 465 | CRP, C3a, C5a, angiopoietin-1, -2, sTie-2, sEndoglin, VEGF, sFlt-1, tissue factor, leptin | Not specified | Non-comparative | Prognostic value of CRP for malaria |
Paul et al.95 | 2012 | India | Outpatient | Prospective | Malaria | 71 | CRP | ≤5 mg/L | Non-comparative | Prognostic value of CRP for malaria |
Mendonca et al.96 | 2013 | Brazil | Outpatient | Retrospective | Malaria | 530 | CRP, liver transaminases, bilirubins, creatinine, fibrinogen, SOD-1, HO-1, cytokines, chemokines | Not specified | Non-comparative | Prognostic value of CRP for malaria |
Bhardwaj, et al.97 | 2019 | India | Inpatient | Prospective | Malaria | 96 | CRP | Not applicable | Non-comparative | Prognostic value of CRP for malaria |
Lima-Junior et al.98 | 2012 | Brazil | Outpatient | Prospective | Malaria | 71 | CRP, NO, platelets, neutrophils | 0.01–320 μg/mL | Non-comparative | Prognostic value of CRP for malaria |
AEC, absolute eosinophil count; ApoA-1, apolipoprotein A1; Apo-CIII, apolipoprotein CIII; ARDS, acute respiratory distress syndrome; ATB, antibiotic; BNP, brain natriuretic peptide; CCL, C motif chemokine ligand; CFH, complement factor H; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; CXCL10, CXC motif chemokine 10; CXR, chest X-ray; ESR, erythrocyte sedimentation rate; esRAGE, endogenous secretory receptor for advanced glycation end products; Hb, haemoglobin; HMGB-1, high-mobility group protein 1; HO-1, haem oxygenase 1; IL-1ra, interleukin-1 receptor antagonist; IP-10, interferon gamma inducible protein 10; LBP, lipopolysaccharide-binding protein; LDH, lactate dehydrogenase; Lyt A, autolysin A; MIF, macrophage migration inhibitory factor; MMP, matrix metalloproteinase; MR-proANP, midregional pro-atrial natriuretic peptide; NCAM, neural cell adhesion molecule; NO, nitric oxide; PCT, procalcitonin; S100A12, S100 calcium binding protein A12; SAA, serum amyloid A; SAP, serum amyloid P-component; sCD, soluble cluster of differentiation; sCD40L, soluble CD40 ligand; sFlt-1, soluble Fms-like tyrosine kinase-1; SOD-1, superoxide dismutase 1; sRAGE, soluble receptor for advanced glycation end products; sTie-2, soluble tyrosine-kinase-receptor; suPAR, soluble urokinase-type plasminogen activator receptor; TBARS, thiobarbituric acid reactive substances; TFsat, transferrin saturation; TGF-α, transforming growth factor-α; TIBC, total iron-binding capacity; TLC, total leukocyte count; TNFR p55, tumour necrosis factor receptor p55; TPA, tissue polypeptide antigen; VEGF, vascular endothelial growth factor.